Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives

BACKGROUND: Actinic keratosis (AK) represents a risk of progression to squamous cell carcinoma. Ingenol mebutate gel is a novel therapeutic option for field-directed treatment. OBJECTIVES: To evaluate the safety, tolerability and patients' perspectives, related to the therapeutic success of man...

Descripción completa

Detalles Bibliográficos
Autores principales: Gameiro, Luiz, Tovo, Luis Fernando Requejo, Sanches Júnior, José Antonio, Aprahamian, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2019
Materias:
Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668952/
https://www.ncbi.nlm.nih.gov/pubmed/31365660
http://dx.doi.org/10.1590/abd1806-4841.20197938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668952/
https://www.ncbi.nlm.nih.gov/pubmed/31365660
http://dx.doi.org/10.1590/abd1806-4841.20197938

Ejemplares similares